Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84
United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Mary C Beckerle
10 Aug 2026
Director
Sold on a plan
9,812
$53.66
$526.51K
Sue Gail Eckhardt
1 Jun 2026
Director
Sold on a plan
9,812
$50.14
$491.97K
Jack L Wyszomierski
1 Jun 2026
Director
Sold on a plan
3,925
$50.55
$198.41K
Dana Aftab
26 May 2026
EVP, Research and Development
Sell
43,451
$50.35
$2.19M
Patrick J. Haley
20 May 2026
EVP, Commercial
Sell
32,110
$49.81
$1.60M
Brenda Hefti
18 May 2026
SVP and General Counsel
Sold on a plan
6,625
$50.21
$332.64K
Christopher J. Senner
18 May 2026
EVP and CFO
Sell
34,901
$50.00
$1.75M
George Poste
7 May 2026
Director
Sell
60,000
$45.71
$2.74M
Maria C Freire
7 May 2026
Director
Sold after exercise
20,634
$46.00
$949.16K
Mary C Beckerle
7 May 2026
Director
Sold after exercise
7,712
$48.45
$373.65K
Dana Aftab
24 Feb 2026
EVP, Research and Development
Sell
47,918
$44.50
$2.13M
Dana Aftab
19 Feb 2026
EVP, Research and Development
Sell
29,873
$44.35
$1.32M
Brenda Hefti
18 Feb 2026
SVP and General Counsel
Sold on a plan
18,669
$44.01
$821.62K
Julie Smith
18 Feb 2026
Director
Sold after exercise
20,030
$44.30
$887.33K
Julie Smith
18 Feb 2026
Director
Sold after exercise
44,087
$44.50
$1.96M
Jack L Wyszomierski
18 Feb 2026
Director
Sold after exercise
99,574
$44.01
$4.38M
Patrick J. Haley
17 Feb 2026
EVP, Commercial
Sell
64,778
$43.50
$2.82M
Patrick J. Haley
17 Feb 2026
EVP, Commercial
Sell
3,036
$43.84
$133.10K
Christopher J. Senner
17 Feb 2026
EVP and CFO
Sell
30,617
$43.67
$1.34M
Julie Smith
17 Feb 2026
Director
Sold after exercise
42,422
$43.33
$1.84M
Bob Oliver
13 Feb 2026
Director
Sold after exercise
21,162
$43.90
$929.01K
Bob Oliver
13 Feb 2026
Director
Sold after exercise
9,088
$43.61
$396.33K
Sue Gail Eckhardt
13 Feb 2026
Director
Sold on a plan
3,856
$43.79
$168.85K
Michael Morrissey
13 Feb 2026
President and CEO
Exercised, kept
494,700
$21.31
$10.54M
Christopher J. Senner
13 Feb 2026
EVP and CFO
Sell
34,278
$43.00
$1.47M
David Edward Johnson
25 Nov 2025
Director
Buy indirect
27,532
$43.12
$1.19M
Patrick J. Haley
21 Nov 2025
EVP, Commercial
Sell
28,043
$42.58
$1.19M
Patrick J. Haley
20 Nov 2025
EVP, Commercial
Sell indirect
10,648
$41.77
$444.77K
Patrick J. Haley
20 Nov 2025
EVP, Commercial
Sell indirect
23,539
$41.93
$986.99K
Patrick J. Haley
20 Nov 2025
EVP, Commercial
Sell
10,000
$42.11
$421.10K
Stelios Papadopoulos
12 Nov 2025
Director
Sell
100,000
$43.55
$4.36M
Mary C Beckerle
11 Nov 2025
Director
Sold after exercise
18,838
$41.90
$789.31K
Mary C Beckerle
11 Nov 2025
Director
Sold after exercise
5,784
$42.03
$243.10K
Dana Aftab
11 Nov 2025
EVP, Research and Development
Sell
48,383
$42.50
$2.06M
Jack L Wyszomierski
3 Jun 2025
Director
Sold on a plan
7,535
$43.09
$324.68K
Sue Gail Eckhardt
2 Jun 2025
Director
Sold on a plan
4
$43.67
$174.68
Sue Gail Eckhardt
2 Jun 2025
Director
Sold on a plan
18,834
$42.74
$804.97K
Tomas J. Heyman
21 May 2025
Director
Sell
4,544
$44.29
$201.25K
Patrick J. Haley
20 May 2025
EVP, Commercial
Sell
34,387
$44.06
$1.52M
Amy C. Peterson
16 May 2025
EVP Prod Dev & Med Aff & CMO
Sold after exercise
72,776
$45.47
$3.31M
Christopher J. Senner
16 May 2025
EVP and CFO
Sold after exercise
100,000
$46.00
$4.60M
George Poste
16 May 2025
Director
Sold after exercise
20,634
$45.99
$948.96K
Patrick J. Haley
15 May 2025
EVP, Commercial
Sold after exercise
116,383
$48.05
$5.59M
Patrick J. Haley
15 May 2025
EVP, Commercial
Sold after exercise
10,000
$46.95
$469.50K
Jeffrey Hessekiel
15 May 2025
EVP & General Counsel
Sell
25,000
$46.18
$1.15M
Stelios Papadopoulos
15 May 2025
Director
Sold after exercise
15,874
$44.35
$704.01K
Stelios Papadopoulos
15 May 2025
Director
Sold after exercise
20,634
$44.35
$915.12K
Patrick J. Haley
14 May 2025
EVP, Commercial
Sold on a plan
10,000
$42.68
$426.80K
Michael Morrissey
14 May 2025
President and CEO
Exercised, kept
308,365
$18.80
$5.80M
Dana Aftab
1 May 2025
CSO/EVP Disc & Trans Research
Sold on a plan
1,508
$39.00
$58.81K
Patrick J. Haley
3 Mar 2025
EVP, Commercial
Sold on a plan
10,000
$38.80
$388.00K
Jack L Wyszomierski
28 Feb 2025
Director
Sold after exercise
8,768
$37.80
$331.43K
Julie Smith
28 Feb 2025
Director
Sold after exercise
19,294
$37.62
$725.84K
Julie Smith
27 Feb 2025
Director
Sold after exercise
54,514
$38.13
$2.08M
Bob Oliver
25 Feb 2025
Director
Sold after exercise
18,647
$37.25
$694.60K
Christopher J. Senner
24 Feb 2025
EVP and CFO
Sold after exercise
29,314
$36.14
$1.06M
Dana Aftab
24 Feb 2025
CSO/EVP Disc & Trans Research
Sell
26,987
$36.75
$991.77K
Patrick J. Haley
24 Feb 2025
EVP, Commercial
Sell
52,636
$36.98
$1.95M
Sue Gail Eckhardt
14 Feb 2025
Director
Sold after exercise
3,856
$35.04
$135.11K
Sue Gail Eckhardt
14 Feb 2025
Director
Sold after exercise
7,712
$35.01
$270.00K
Maria C Freire
14 Feb 2025
Director
Sold after exercise
44,114
$34.94
$1.54M
George Poste
14 Feb 2025
Director
Sold after exercise
15,874
$34.74
$551.46K
Mary C Beckerle
14 Feb 2025
Director
Sold after exercise
3,856
$34.90
$134.57K
Mary C Beckerle
14 Feb 2025
Director
Sold after exercise
8,354
$34.87
$291.30K
Jeffrey Hessekiel
29 Nov 2024
EVP & General Counsel
Sell
60,000
$36.67
$2.20M
Jeffrey Hessekiel
27 Nov 2024
EVP & General Counsel
Exercised, kept
129,314
$18.80
$2.43M
Patrick J. Haley
22 Nov 2024
EVP, Commercial
Sold on a plan
10,000
$35.27
$352.70K
Patrick J. Haley
18 Nov 2024
EVP, Commercial
Sold on a plan
19,381
$34.41
$666.90K
Patrick J. Haley
18 Nov 2024
EVP, Commercial
Sold on a plan
22,207
$34.31
$761.92K
Dana Aftab
5 Nov 2024
CSO/EVP Disc & Trans Research
Sold after exercise
96,986
$35.00
$3.39M
George Poste
1 Nov 2024
Director
Sell
30,000
$34.00
$1.02M
Jeffrey Hessekiel
1 Nov 2024
EVP & General Counsel
Sold on a plan
50,000
$34.13
$1.71M
Dana Aftab
30 Oct 2024
CSO/EVP Disc & Trans Research
Sold on a plan
1,162
$31.40
$36.49K
Jeffrey Hessekiel
28 Oct 2024
EVP & General Counsel
Sold on a plan
25,000
$28.39
$709.75K
Patrick J. Haley
2 Oct 2024
EVP, Commercial
Exercised, kept
100,000
$24.41
$2.44M
Michael Morrissey
1 Oct 2024
President and CEO
Exercised, kept
480,000
$24.41
$11.72M
Jeffrey Hessekiel
23 Sep 2024
EVP & General Counsel
Sold on a plan
25,000
$26.38
$659.50K
Jeffrey Hessekiel
26 Aug 2024
EVP, General Counsel & Sec
Sold after exercise
20,000
$25.79
$515.80K
Maria C Freire
14 Aug 2024
Director
Sell
8,250
$26.56
$219.12K
Dana Aftab
12 Aug 2024
CSO/EVP Disc & Trans Research
Sell
20,883
$27.06
$565.09K
Christopher J. Senner
9 Aug 2024
EVP and CFO
Sold after exercise
125,000
$27.19
$3.40M
George Poste
8 Aug 2024
Director
Sell
33,725
$26.89
$906.87K
Jeffrey Hessekiel
7 Aug 2024
EVP, General Counsel & Sec
Sold after exercise
80,000
$25.97
$2.08M
Patrick J. Haley
7 Aug 2024
EVP, Commercial
Sold on a plan
14,000
$25.50
$357.00K
Dana Aftab
7 Aug 2024
CSO/EVP Disc & Trans Research
Sold after exercise
95,000
$25.00
$2.38M
Jack L Wyszomierski
4 Jun 2024
Director
Sold on a plan
8,287
$22.00
$182.31K
David Edward Johnson
30 May 2024
Director
Buy indirect
225,000
$20.76
$4.67M
David Edward Johnson
28 May 2024
Director
Buy indirect
200,000
$20.32
$4.06M
George Poste
21 May 2024
Director
Sold after exercise
11,686
$20.96
$244.94K
Julie Smith
21 May 2024
Director
Sell
27,280
$21.12
$576.15K
Stelios Papadopoulos
20 May 2024
Director
Sold after exercise
11,437
$21.00
$240.18K
Jack L Wyszomierski
13 May 2024
Director
Sold after exercise
10,923
$21.37
$233.42K
Alan M Garber
21 Mar 2024
Director
Sold after exercise
19,205
$24.01
$461.11K
Patrick J. Haley
23 Feb 2024
EVP, Commercial
Sell
47,020
$21.45
$1.01M
David Edward Johnson
21 Feb 2024
Director
Buy indirect
190,000
$20.70
$3.93M
Patrick J. Haley
14 Dec 2023
EVP, Commercial
Sold after exercise
50,000
$23.35
$1.17M
Jeffrey Hessekiel
13 Dec 2023
EVP, General Counsel & Sec
Sold on a plan
25,000
$23.01
$575.25K
Patrick J. Haley
12 Dec 2023
EVP, Commercial
Sold on a plan
14,149
$22.50
$318.35K
Jeffrey Hessekiel
4 Dec 2023
EVP, General Counsel & Sec
Sold on a plan
25,000
$22.06
$551.50K
Jeffrey Hessekiel
30 Nov 2023
EVP, General Counsel & Sec
Sold on a plan
25,000
$22.01
$550.25K
David Edward Johnson
27 Nov 2023
Director
Buy indirect
120,409
$21.61
$2.60M
David Edward Johnson
27 Nov 2023
Director
Sell indirect
120,409
$21.61
$2.60M
Dana Aftab
30 Aug 2023
CSO/EVP Disc & Trans Research
Sold on a plan
4,600
$22.47
$103.36K
Michael Morrissey
28 Aug 2023
President and CEO
Exercised, kept
360,000
$15.31
$5.51M
Christopher J. Senner
4 Aug 2023
EVP and CFO
Sold after exercise
60,000
$20.68
$1.24M
Patrick J. Haley
3 Aug 2023
EVP, Commercial
Sell
30,553
$20.67
$631.53K
Christopher J. Senner
3 Aug 2023
EVP and CFO
Sold after exercise
60,000
$20.51
$1.23M
Jeffrey Hessekiel
1 Aug 2023
EVP, General Counsel & Sec
Sold after exercise
55,710
$19.63
$1.09M
Jeffrey Hessekiel
5 Apr 2023
EVP, General Counsel & Sec
Sold after exercise
38,930
$20.01
$778.99K
Jack L Wyszomierski
10 Mar 2023
Director
Sold after exercise
15,300
$16.61
$254.13K
Jeffrey Hessekiel
1 Mar 2023
EVP, General Counsel & Sec
Sold after exercise
77,860
$17.13
$1.33M
Dana Aftab
28 Feb 2023
CSO/EVP Disc & Trans Research
Sold after exercise
82,490
$17.50
$1.44M
Dana Aftab
27 Feb 2023
CSO/EVP Disc & Trans Research
Sold after exercise
10
$17.50
$175.00
Alan M Garber
21 Feb 2023
Director
Sold after exercise
40,000
$17.49
$699.60K
Carl B Feldbaum
9 Feb 2023
Director
Sold after exercise
40,000
$17.78
$711.20K
Patrick J. Haley
6 Feb 2023
EVP, Commercial
Sold after exercise
25,000
$17.37
$434.25K
Michael Morrissey
24 Jan 2023
President and CEO
Exercised, kept
100,000
$4.20
$420.00K
Peter Lamb
15 Dec 2022
EVP, Scientific Strategy & CSO
Sold after exercise
20,000
$15.88
$317.60K
George Poste
29 Nov 2022
Director
Sold after exercise
40,000
$16.68
$667.20K
Patrick J. Haley
12 Sep 2022
EVP, Commercial
Sold after exercise
40,000
$17.94
$717.60K
Christopher J. Senner
11 Aug 2022
EVP and CFO
Exercised, kept
225,000
$6.21
$1.40M
Patrick J. Haley
27 May 2022
EVP, Commercial
Sell
18,812
$18.21
$342.57K
Jeffrey Hessekiel
16 May 2022
EVP, General Counsel & Sec
Sell
18,000
$20.07
$361.26K
Lance Willsey
12 May 2022
Director
Sold after exercise
40,000
$19.65
$786.00K
Jack L Wyszomierski
4 Apr 2022
Director
Sold after exercise
6,696
$23.00
$154.01K
Patrick J. Haley
1 Apr 2022
EVP, Commercial
Sold after exercise
10,000
$23.00
$230.00K
Patrick J. Haley
31 Mar 2022
EVP, Commercial
Sold after exercise
10,000
$22.43
$224.30K
Jeffrey Hessekiel
29 Mar 2022
EVP, General Counsel & Sec
Sell
13,283
$22.00
$292.23K
Jeffrey Hessekiel
28 Mar 2022
EVP, General Counsel & Sec
Sell
4,717
$22.00
$103.77K
Alan M Garber
1 Mar 2022
Director
Sold after exercise
21,301
$21.00
$447.32K
Patrick J. Haley
25 Feb 2022
EVP, Commercial
Sell
31,238
$19.53
$610.08K
Jeffrey Hessekiel
24 Feb 2022
EVP and General Counsel
Sell
18,000
$20.00
$360.00K
Carl B Feldbaum
22 Feb 2022
Director
Sold after exercise
20,000
$19.49
$389.80K
Stelios Papadopoulos
22 Feb 2022
Director
Sell
84,515
$19.56
$1.65M
Patrick J. Haley
3 Feb 2022
EVP, Commercial
Sold after exercise
60,000
$17.91
$1.07M
Peter Lamb
15 Dec 2021
EVP, Scientific Strategy & CSO
Sold after exercise
47,500
$17.44
$828.40K
Patrick J. Haley
24 Nov 2021
EVP, Commercial
Sell
17,236
$17.25
$297.32K
Carl B Feldbaum
19 Nov 2021
Director
Sold after exercise
20,000
$17.62
$352.40K
Peter Lamb
15 Nov 2021
EVP, Scientific Strategy & CSO
Sold after exercise
47,500
$18.09
$859.28K
Jeffrey Hessekiel
1 Nov 2021
EVP and General Counsel
Sell
5,117
$22.03
$112.73K
Jeffrey Hessekiel
15 Oct 2021
EVP and General Counsel
Sell
12,883
$22.02
$283.68K
Peter Lamb
15 Oct 2021
EVP, Scientific Strategy & CSO
Sold after exercise
47,500
$21.92
$1.04M
Christopher J. Senner
21 Sep 2021
EVP and CFO
Exercised, kept
90,000
$3.66
$329.40K
Patrick J. Haley
16 Sep 2021
EVP, Commercial
Sold after exercise
25,000
$20.36
$509.00K
Peter Lamb
15 Sep 2021
EVP, Scientific Strategy & CSO
Sold after exercise
47,500
$20.46
$971.85K
Peter Lamb
16 Aug 2021
EVP, Scientific Strategy & CSO
Sold after exercise
55,000
$18.44
$1.01M
Gisela Schwab
26 Jul 2021
Pres, Prod Dev & Med Aff & CMO
Exercised, kept
40,000
$4.20
$168.00K
Gisela Schwab
21 Jul 2021
Pres, Prod Dev & Med Aff & CMO
Exercised, kept
35,000
$4.20
$147.00K
Peter Lamb
15 Jul 2021
EVP, Scientific Strategy & CSO
Sold after exercise
60,000
$17.47
$1.05M
Charles Cohen
6 Jul 2021
Director
Exercised, kept
40,000
$6.30
$252.00K
Charles Cohen
6 Jul 2021
Director
Exercised, kept
40,000
$3.13
$125.20K
Peter Lamb
17 Jun 2021
EVP, Scientific Strategy & CSO
Sold after exercise
60,000
$22.18
$1.33M
Patrick J. Haley
18 May 2021
EVP, Commercial
Sell
14,593
$24.73
$360.88K
Jeffrey Hessekiel
17 May 2021
EVP, General Counsel & Sec
Sell
18,000
$25.39
$457.02K
George Poste
14 May 2021
Director
Sell
40,802
$24.97
$1.02M
Vincent T Marchesi
14 May 2021
Director
Sold after exercise
40,000
$25.04
$1.00M
Gisela Schwab
13 May 2021
Pres, Prod Dev & Med Aff & CMO
Sold after exercise
100,000
$25.38
$2.54M
Michael Morrissey
12 May 2021
President and CEO
Exercised, kept
50,000
$4.20
$210.00K
Stelios Papadopoulos
11 May 2021
Director
Sold after exercise
5,473
$25.01
$136.88K
Stelios Papadopoulos
11 May 2021
Director
Sold after exercise
5,075
$25.00
$126.88K
Stelios Papadopoulos
11 May 2021
Director
Sold after exercise
10,222
$24.95
$255.04K
Maria C Freire
11 May 2021
Director
Sell
8,275
$25.01
$206.96K
Jeffrey Hessekiel
26 Apr 2021
EVP and General Counsel
Sell
18,000
$25.03
$450.54K
Patrick J. Haley
26 Apr 2021
EVP, Commercial
Sell
7,665
$25.03
$191.85K
Gisela Schwab
26 Apr 2021
Pres, Prod Dev & Med Aff & CMO
Sold after exercise
50,000
$25.00
$1.25M
Gisela Schwab
1 Apr 2021
Pres, Prod Dev & Med Aff & CMO
Sold after exercise
50,000
$23.00
$1.15M
Peter Lamb
1 Apr 2021
EVP, Scientific Strategy & CSO
Sold after exercise
60,000
$22.96
$1.38M
Jack L Wyszomierski
29 Mar 2021
Director
Sold after exercise
6,220
$22.64
$140.82K
Alan M Garber
15 Mar 2021
Director
Sold after exercise
40,000
$23.60
$944.00K
Peter Lamb
1 Mar 2021
EVP, Scientific Strategy & CSO
Sold after exercise
65,000
$22.11
$1.44M
Charles Cohen
24 Feb 2021
Director
Sold after exercise
40,000
$22.69
$907.60K
Lance Willsey
23 Feb 2021
Director
Sold after exercise
800
$22.34
$17.87K
Lance Willsey
23 Feb 2021
Director
Sold after exercise
39,200
$21.92
$859.26K
Vincent T Marchesi
22 Feb 2021
Director
Sell
24,097
$22.29
$537.12K
George Poste
22 Feb 2021
Director
Exercised, kept
40,000
$3.38
$135.20K
Gisela Schwab
18 Feb 2021
Pres, Prod Dev & Med Aff & CMO
Sold after exercise
50,000
$22.35
$1.12M
Gisela Schwab
17 Feb 2021
Pres, Prod Dev & Med Aff & CMO
Sold after exercise
50,000
$22.50
$1.13M
Carl B Feldbaum
16 Feb 2021
Director
Sold after exercise
20,000
$21.96
$439.20K
Lance Willsey
16 Feb 2021
Director
Sell
50,000
$21.90
$1.10M
Patrick J. Haley
12 Feb 2021
EVP, Commercial
Sell
45,000
$21.57
$970.65K
Peter Lamb
1 Feb 2021
EVP, Scientific Strategy & CSO
Sold after exercise
65,000
$22.08
$1.44M
Christopher J. Senner
12 Jan 2021
EVP and CFO
Sold after exercise
30,000
$25.00
$750.00K
Jeffrey Hessekiel
4 Jan 2021
EVP and General Counsel
Exercised, kept
20,000
$1.90
$38.00K
Jeffrey Hessekiel
4 Jan 2021
EVP and General Counsel
Exercised, kept
30,000
$7.27
$218.10K
Peter Lamb
4 Jan 2021
EVP, Scientific Strategy & CSO
Sold after exercise
65,000
$20.32
$1.32M
Peter Lamb
18 Dec 2020
EVP, Scientific Strategy & CSO
Sold after exercise
65,000
$20.01
$1.30M
Lance Willsey
4 Dec 2020
Director
Exercised, kept
106,142
$5.82
$617.75K
Vincent T Marchesi
24 Nov 2020
Director
Sold after exercise
40,004
$18.50
$740.07K
Jeffrey Hessekiel
15 Nov 2020
EVP and General Counsel
Exercised, kept
30,000
$7.27
$218.10K
Jack L Wyszomierski
10 Nov 2020
Director
Sold after exercise
34,000
$20.61
$700.74K
Jeffrey Hessekiel
21 Oct 2020
EVP and General Counsel
Sold after exercise
39,742
$21.95
$872.34K
Christopher J. Senner
8 Oct 2020
EVP and CFO
Sold after exercise
10,000
$25.00
$250.00K
Jeffrey Hessekiel
22 Sep 2020
EVP and General Counsel
Sold after exercise
10,258
$26.14
$268.14K
Patrick J. Haley
21 Sep 2020
EVP, Commercial
Sold after exercise
4,680
$26.09
$122.10K
Jeffrey Hessekiel
16 Sep 2020
EVP and General Counsel
Sold after exercise
20,000
$26.11
$522.20K
Christopher J. Senner
15 Sep 2020
EVP and CFO
Sold after exercise
20,000
$25.00
$500.00K
Jeffrey Hessekiel
8 Sep 2020
EVP and General Counsel
Exercised, kept
190,000
$6.21
$1.18M
Jeffrey Hessekiel
8 Sep 2020
EVP and General Counsel
Exercised, kept
59,692
$1.90
$113.41K
Charles Cohen
1 Sep 2020
Director
Exercised, kept
115,396
$5.82
$671.60K
George Poste
14 Aug 2020
Director
Exercised, kept
29,662
$5.82
$172.63K
Patrick J. Haley
20 Jul 2020
EVP, Commercial
Sell
3,151
$25.36
$79.91K
Michael Morrissey
20 Jul 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
Michael Morrissey
10 Jul 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
Michael Morrissey
19 Jun 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
Peter Lamb
8 Jun 2020
EVP, Scientific Strategy & CSO
Sold after exercise
26,000
$22.56
$586.56K
Gisela Schwab
4 Jun 2020
Pres, Prod Dev & Med Aff & CMO
Sold after exercise
100,000
$22.96
$2.30M
Michael Morrissey
29 May 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
Alan M Garber
22 May 2020
Director
Sell
36,111
$24.42
$881.83K
Vincent T Marchesi
21 May 2020
Director
Sold after exercise
40,000
$24.64
$985.60K
Patrick J. Haley
20 May 2020
EVP, Commercial
Sell
3,151
$24.99
$78.74K
George A Scangos
18 May 2020
Director
Sell
75,000
$25.96
$1.95M
Lance Willsey
18 May 2020
Director
Sold after exercise
30,000
$26.26
$787.80K
George A Scangos
15 May 2020
Director
Exercised, kept
21,686
$5.82
$126.21K
George A Scangos
15 May 2020
Director
Exercised, kept
30,000
$4.58
$137.40K
Michael Morrissey
15 May 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
Lance Willsey
14 May 2020
Director
Sold after exercise
15,000
$25.26
$378.90K
Stelios Papadopoulos
13 May 2020
Director
Exercised, kept
120,791
$5.82
$703.00K
Jeffrey Hessekiel
13 May 2020
EVP and General Counsel
Exercised, kept
25,000
$1.70
$42.50K
Jeffrey Hessekiel
11 May 2020
EVP and General Counsel
Sold after exercise
38,006
$27.09
$1.03M
Vincent T Marchesi
11 May 2020
Director
Sold after exercise
30,000
$26.30
$789.00K
Patrick J. Haley
8 May 2020
EVP, Commercial
Sold after exercise
21,375
$25.87
$552.97K
Stelios Papadopoulos
8 May 2020
Director
Sold after exercise
45,000
$25.84
$1.16M
Christopher J. Senner
8 May 2020
EVP and CFO
Sold after exercise
78,583
$25.81
$2.03M
Jeffrey Hessekiel
8 May 2020
EVP and General Counsel
Sold after exercise
25,000
$26.04
$651.00K
Peter Lamb
7 May 2020
EVP, Scientific Strategy & CSO
Sold after exercise
50,000
$25.54
$1.28M
George Poste
7 May 2020
Director
Sold after exercise
30,000
$25.61
$768.30K
Carl B Feldbaum
7 May 2020
Director
Sold after exercise
31,546
$25.02
$789.28K
Christopher J. Senner
7 May 2020
EVP and CFO
Sold after exercise
21,417
$25.80
$552.56K
Jeffrey Hessekiel
7 May 2020
EVP and General Counsel
Sold after exercise
30,000
$25.61
$768.30K
Michael Morrissey
6 May 2020
President and CEO
Exercised, kept
285,284
$1.70
$484.98K
Michael Morrissey
27 Apr 2020
President and CEO
Exercised, kept
285,000
$1.70
$484.50K
George A Scangos
24 Apr 2020
Director
Sell
15,000
$26.24
$393.60K
Patrick J. Haley
23 Apr 2020
EVP, Commercial
Sold after exercise
5,000
$26.00
$130.00K
George A Scangos
23 Apr 2020
Director
Sell
55,700
$26.23
$1.46M
George A Scangos
23 Apr 2020
Director
Sell
44,300
$25.68
$1.14M
Gisela Schwab
23 Apr 2020
Pres, Prod Dev & Med Aff & CMO
Sold after exercise
100,000
$26.00
$2.60M
Michael Morrissey
23 Apr 2020
President and CEO
Exercised, kept
250,000
$5.51
$1.38M
George A Scangos
22 Apr 2020
Director
Sell
4,200
$25.05
$105.21K
Michael Morrissey
21 Apr 2020
President and CEO
Exercised, kept
220,000
$5.51
$1.21M
George A Scangos
21 Apr 2020
Director
Sell
5,800
$25.04
$145.23K
Michael Morrissey
20 Apr 2020
President and CEO
Exercised, kept
240,000
$5.51
$1.32M
Patrick J. Haley
20 Apr 2020
EVP, Commercial
Sold after exercise
5,000
$24.00
$120.00K
George A Scangos
20 Apr 2020
Director
Sell
5,900
$24.70
$145.73K
George A Scangos
20 Apr 2020
Director
Sell
25,600
$24.07
$616.19K
George A Scangos
20 Apr 2020
Director
Sell
18,500
$23.39
$432.72K
George A Scangos
15 Apr 2020
Director
Sell
25,000
$18.31
$457.75K
George A Scangos
8 Apr 2020
Director
Sell
7,065
$18.35
$129.64K
George A Scangos
7 Apr 2020
Director
Sell
16,435
$18.25
$299.94K
Peter Lamb
6 Apr 2020
EVP, Scientific Strategy & CSO
Sold after exercise
50,000
$17.26
$863.00K
Jack L Wyszomierski
3 Apr 2020
Director
Sold after exercise
13,848
$16.57
$229.46K
Showing 250 of 499 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 706
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 283
Sales at will 131
Transactions with no price 0
Shares from compensation/vesting 41,557,913
Sales filed before the plan box existed 101
History held since 6 Oct 2006